ReviewCureus2026
Integrated Management Strategies for Diabetes Mellitus and Hypertension: A Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus (DM) and hypertension frequently coexist and together substantially increase the risk of cardiovascular morbidity, mortality, and healthcare burden worldwide. Despite growing recognition of their shared pathophysiology, clinical management often remains fragmented, creating uncertainty regarding the optimal integration of care strategies. This systematic review aimed to synthesise current evidence on integrated management approaches for adults with coexisting DM and hypertension, with emphasis on intervention models and clinical outcomes. A systematic literature search was conducted in PubMed, Scopus, and Web of Science for studies published between 2015 and 2025. Eligible studies included randomised controlled trials and comparative observational studies evaluating integrated or combined management strategies. Eleven studies met the inclusion criteria and were synthesised systematically due to heterogeneity in study designs and outcome reporting. Integrated interventions commonly combined pharmacological optimisation, lifestyle modification, multidisciplinary team care, and technology-assisted support. Reported outcomes included improvements in glycaemic control, blood pressure regulation, cardiometabolic risk factors, and care process indicators. The findings highlight the consistent application of coordinated care frameworks across diverse healthcare settings, reflecting a shift toward comprehensive cardiometabolic risk management. Integrated strategies demonstrate potential to enhance care coordination, patient engagement, and alignment with patient-centred care models. The evidence supports integrated management as a viable and clinically relevant approach for addressing the complex needs of individuals with coexisting DM and hypertension, reinforcing the importance of coordinated strategies in contemporary chronic disease management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.